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a  b  s  t  r  a  c  t
The  efﬁcacy  of a novel  topical  ﬁpronil,  (S)-methoprene,  eprinomectin  and praziquantel
combination  product  (BROADLINE®, Merial)  was  evaluated  against  adult  Toxascaris  leon-
ina ascarids  in  experimentally  infected  cats in  two controlled  studies  under  an  identical
protocol.  For  each  study,  30 nematode-naive,  purpose-bred  European  Short  Hair  cats  were
inoculated  orally  with  approximately  300  larvated  T. leonina  eggs.  Twenty-two  and  24  cats,
respectively,  that  were  shown  to be  positive  for Toxascaris  eggs  by pre-treatment  faecal
examination  were  subsequently  included  in  the two studies.  In each  study,  the  animals
were  allocated  randomly  to  an  untreated  (control)  group  or to a  treatment  group.  The
treatment  was a novel  topical  combination:  ﬁpronil  (8.3%,  w/v),  (S)-methoprene  (10%,  w/v),
eprinomectin  (0.4%  w/v)  and  praziquantel  (8.3%  w/v).  Treatment  was  applied  on  Day  0 at
0.12 mL/kg  bodyweight.  For  parasite  recovery  and count,  cats  were  euthanized  humanely
seven  days  after  treatment  and  necropsied.  All  untreated  cats  harboured  adult  T. leonina
(range,  1–31  nematodes).  The  treatment  provided  a high  level  of  efﬁcacy  against  adult
T. leonina  in  both  studies  (95.8%  and  98.1%,  respectively  p < 0.001).  All cats  accepted  the
treatment  well  based  on hourly  post-treatment  observations  for  4  h  and  daily  observations
thereafter.  No  adverse  experiences  or other  health  problems  were  observed  throughout  the
studies.  Thus  the data  indicate  that  this  novel  combination  product  will provide  a safe  and
effective treatment  against  T.  leonina  in  cats.
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1. Introduction
There are two species of ascarids affecting cats and kit-
tens: Toxocara cati and Toxascaris leonina. Toxocara cati
is the most common nematode parasite of cats while T.
leonina is less common. In contrast to Toxocara cati being
 Broadline® is a trademark of Merial; all other marks are the property
of  their respective owners.
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licenses/by-nc-nd/3.0/).lished  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
speciﬁc to cats, T. leonina can complete its life cycle in sev-
eral host species, primarily including domestic and wild
canids (dogs and foxes), but it also infects felids (Sprent,
1959; Bowman et al., 2002).
T. leonina infections have been demonstrated in several
cat parasite surveys worldwide (Parsons, 1987). Relevant
information on the current occurrence of Toxascaris infec-
tions in domestic cats of different categories is available
through coproscopical and autopsy surveys conducted on
all continents: Africa (Khalafalla, 2011; Sowemimo, 2012),
Asia (e.g. Schuster et al., 2009; Abu-Madi et al., 2010; Borji
et al., 2011; Al-Obaidi, 2012; Itoh et al., 2012), Australia
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McGlade et al., 2003; Palmer et al., 2008; Bissett et al.,
009), Europe (e.g. Duarte et al., 2010; Ładczuk and Balicka-
amisz, 2010; Thomas et al., 2010; Barutzki and Schaper,
011; Capári et al., 2013; Mugnaini et al., 2012; Näreaho
t al., 2012), North America (Gates and Nolan, 2009;
lagburn et al., 2012) and South America (Labarthe et al.,
004; Sommerfelt et al., 2006). Rates of T. leonina infec-
ion show large variability between surveys with generally
ower frequencies observed in the northern hemisphere.
he highest prevalence reported was 30% through autopsy
f cats (Al-Obaidi, 2012) or 23.5% by faecal examination
Sowemimo, 2012). As with Toxocara cati, younger cats are
ore likely to harbour T. leonina infections (McGlade et al.,
003; Capári et al., 2013). Concomitant Toxascaris and Tox-
cara infections appear to be very rare in cats (Parsons,
987). However, an exceptionally high rate of concurrent
oxascaris and Toxocara presence has been described in the
at population of a farm in England (Yamaguchi et al., 1996),
ndicating special endemic and close contact conditions.
Although infections of cats by T. leonina may  be well
olerated and there is no evidence of zoonotic potential for
his parasite, infections should be controlled appropriately
or hygienic reasons and to reduce the transmission of this
arasite. Cat isolates are infectious for both cats and dogs
hile isolates derived from dogs have been shown to be
nlikely to establish in cats (Sprent, 1959; Okoshi and Usui,
968; Fukase et al., 1987).
The two studies reported here were designed to evalu-
te the efﬁcacy of a novel topical combination formulation
f ﬁpronil, (S)-methoprene, eprinomectin and praziquantel
gainst adult T. leonina ascarids in cats.
. Materials and methods
The study design was in accordance with the Inter-
ational Cooperation on Harmonisation of Technical
equirements for Registration of Veterinary Medicinal
roducts (VICH) – GL7, “Efﬁcacy of Anthelmintics: Gen-
ral Requirements” (Vercruysse et al., 2001), VICH GL20
Efﬁcacy of Anthelmintics: Speciﬁc Recommendations
or Felines” (Vercruysse et al., 2002), and the “World
ssociation for the Advancement of Veterinary Parasito-
ogy (WAAVP) guidelines for evaluating the efﬁcacy of
nthelmintics for dogs and cats” (Jacobs et al., 1994). All
tudies were conducted in compliance with VICH GL9, enti-
led Good Clinical Practice and in compliance with local
nimal welfare legislation and were approved by an Inde-
endent Animal Care and Use Committee. All personnel
nvolved in collecting efﬁcacy data were blinded to the
reatment assigned to the animals.
.1. Experimental animals
In each study, following an acclimation period, 30
ealthy, purpose-bred European Short Hair cats were inoc-
lated orally with Toxascaris eggs. At the start of the study,
he cats were nematode-free as conﬁrmed by standard
aecal examination techniques prior to initial inoculation.
ased on pre-treatment faecal examination, 22 and 24 cats
ere included in Study 1 and Study 2, respectively. The
nimals weighed between 1.214 kg and 3.178 kg prior totology 202 (2014) 40–44 41
treatment and were approximately 5–8 months old (details
are shown in Table 1). In both studies, cats were housed
in group runs until nine days before treatment when they
were transferred to individual cages until the end of the
study. The environmental conditions were identical for all
animals within a study.
2.2. Experimental infection and pre-treatment faecal
examination
In each study, 30 cats were each inoculated orally
on three consecutive days (72, 71 and 70 days prior to
treatment) with approximately 100 infective (larvated)
Toxascaris eggs per each day using a disposable syringe. The
Toxascaris eggs were extracted from the faeces of naturally
infected cheetahs from a zoo located in Austria (Study 1)
or a domestic cat living in a cattery in Hungary (Study 2).
The eggs were incubated to become larvated and used for
inoculation within 4 months from isolation.
Faecal samples were collected prior to treatment (Day 0)
starting on Day −8 and examined to conﬁrm the presence
of Toxascaris eggs by using a modiﬁed McMaster technique
(Wetzel, 1951) adjusted to a sensitivity of 25 eggs per gram
of faeces (EPG). In Study 1, 22 of the 30 inoculated cats were
demonstrated shedding Toxascaris eggs (200–1600 EPG)
over a four-day period (nine, eight, four and one cat tested
positive sequentially eight, seven, six or ﬁve days prior to
treatment) and were included in the study. In Study 2, 28
of the 30 inoculated cats shed Toxascaris eggs (25–1950
EPG) when examined eight days prior to treatment, and the
24 cats with the highest faecal egg counts were included
in the study. The cats not included in the study received
anthelmintic treatment.
2.3. Experimental design
The studies were conducted under a single protocol uti-
lizing a randomized block design based on pre-treatment
body weight. Replicates of two  cats were formed sequen-
tially, based on decreasing pre-treatment (Day −2/−1)
body weights. Within replicates, animals were randomly
allocated to groups: one to the untreated (control) group
and one to the treated group.
The treatment, ﬁpronil (8.3%, w/v), (S)-methoprene
(10%, w/v), eprinomectin (0.4%, w/v) and praziquantel
(8.3%, w/v) (Broadline®, Merial) was  administered top-
ically at 0.12 mL/kg bodyweight directly on the skin in
the midline of the neck between the base of the skull
and the shoulder blades in a single spot once on Day 0.
This dosage corresponded to the minimum label dose and
delivered 10 mg  ﬁpronil + 12 mg  (S)-methoprene + 0.5 mg
eprinomectin and 10 mg  praziquantel per kg of body-
weight.
All cats were observed hourly for 4 h post-treatment and
thereafter once daily until end of the study for health prob-
lems or adverse events. For parasite recovery and count,
cats were humanely euthanized seven days after treat-
ment by applying a procedure that was  in accordance with
standard veterinary routine, and necropsied.
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Table 1
Characteristics of experimental animals and results of pre-treatment faecal examination.
Study/group Sexa ∼Age (months) Pre-treatmentb
body weight (kg)
Pre-treatmentc Toxascaris
faecal egg counts, range
Study 1
Untreated control 7 M,  4 F 5–8 1.8–3.2 200–1200 EPGd
Topical FMEPe 6 M,  5 F 5–8 1.9–2.4 150–1600 EPG
Study  2
Untreated control 6 M,  6 F 5–6 1.5–2.3 100–1950 EPG
Topical treatment 7 M,  5 F 5–6 1.2–2.2 100–1850 EPG
a M = male; F = female.
b Day – 1, Study 1 or Day – 2, Study 2 prior to treatment (= Day 0).
 to treat
 (0.4%, wc Established on Days -8, -7, -6 or -5 (Study 1) or Day -8 (Study 2) prior
d EPG = eggs per gram of faeces.
e Topical ﬁpronil (8.3%, w/v), (S)-methoprene (10%, w/v), eprinomectin
2.4. Parasite recovery and count
The contents of the total gastrointestinal tract (stomach,
small and large intestines including cecum) were collected.
To facilitate the isolation and counting of nematodes, organ
contents were screened over 300 m mesh size sieves
to remove the debris. Counts of parasites were made on
total gastrointestinal contents. Nematodes were identiﬁed
by species and stage of development using morphological
characteristics described in Hartwich (1975).
2.5. Data analysis
Adult T. leonina counts were transformed to the nat-
ural logarithm of (count + 1) for calculation of geometric
means for each treatment group. Efﬁcacy for the treated
group was calculated as the percent efﬁcacy using the
formula 100 × [(C − T)/C], were C is the geometric mean
among untreated (control) animals and T is the geometric
mean among the treated animals treated. The log-counts
of the treated group were compared to the log-counts of
the untreated (control) group using an F-test adjusted for
the allocation blocks. The Mixed procedure in SAS® version
9.1.3 was used for this analysis with Group as the ﬁxed
effect and allocation blocks as the random effect. Testing
was two-sided at the  ˛ = 0.05 signiﬁcance level.
3. ResultsNo adverse events or other health problems were
observed after treatment application and throughout the
studies, indicating that treatment was well accepted.
Table 2
Parasite counts and therapeutic efﬁcacy of Broadline® spot on efﬁcacy of against 
Adult Toxascaris leonina counts 
Untreated (control) Treateda
NI/NGd GMe (range) NI/NG 
Study 1 11/11 12.52 (4–25) 4/11 
Study  2 12/12 8.33 (1–31) 2/12 
a Broadline® = ﬁpronil (8.3% w/v), (S)-methoprene (10%, w/v), eprinomectin (0.
b Efﬁcacy = 100 [(geometric mean untreated (control) group – geometric mean
c Two-sided p-value comparing the worm burden of the Topical FMEP group w
d NI/NG: Number of cats Infected/Number of cats in Group.
e Geometric mean count (based on transformation to ln [count + 1]).ment (= Day 0).
/v), and praziquantel (8.3%, w/v); at 0.12 mL/kg body weight.
Both studies met  the recommendations as to adequacy-
of-infection per VICH GL7 and VICH GL20, as ten of 11 or
nine of 12 cats in the untreated (control) groups of Study
1 or 2, respectively, harboured more than the minimum
number of ﬁve adult T. leonina per cat accepted as an ade-
quate infection.
The results of the two studies are summarized in Table 2.
Cats treated with the novel topical combination had signif-
icantly (P < 0.001) fewer adult T. leonina than the untreated
controls with an overall >95% reduction of worm burden. In
addition to adult worms, small numbers of fourth-stage T.
leonina larvae were recovered from some cats in both stud-
ies (1–2 larvae per cat in 4/11 untreated animals vs. zero
larvae in 11 treated animals in Study 1; 1 larva each in 5/12
untreated animals vs. 2 larvae in 1/12 treated animals in
Study 2).
4. Discussion
All untreated control animals harboured adult T. leon-
ina with similar establishment rates (percentage ratio of
number of adult nematodes found at necropsy/number of
larvated eggs inoculated – based on untreated (control)
animals’ counts) of the two T. leonina isolates: 4.76% for
Study 1 and 4.03% for Study 2. This indicated similar sus-
ceptibility of the cats to the different T. leonina isolates
which derived either from a large felid (cheetah, Study 1)
or domestic cats (Study 2). This ﬁnding is in line with the
general conclusions drawn by Okoshi and Usui (1968) from
their experiments in cats with eggs cultured from naturally
infected large captive felids or domestic cats. In contrast
to our ﬁndings, Fukase et al. (1987) found tenfold lower
experimentally induced Toxascaris leonina infection in cats.
Efﬁcacy (%)b p-valuec
GM (range)
0.53 (0–5) 95.8 <0.001
0.16 (0–2) 98.1 <0.001
4%, w/v), and praziquantel (8.3%, w/v); at 0.12 mL/kg body weight.
 Topical FMEP group)/geometric mean untreated (control) group].
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stablishment rates when inoculating of cats with 5000
ggs of cat-derived T. leonina isolates in Japan. However,
xperimental infection of cats with isolates derived from
arge felids may  be challenging and result in variable, and
ven erratic, establishment rates of T. leonina (Reinemeyer
t al., 2005). The duration of the prepatent period also has
een related to the claimed existence of isolates adapted
o speciﬁc hosts or groups of hosts. Using cat-derived eggs
or inoculation of cats, Sprent (1959) found a prepatent
eriod of 74 days, Okoshi and Usui (1968) reported a
repatent period of 62–63 days, and Fukase et al. (1987)
ecorded patent infections in cats as early as 50 days fol-
owing inoculation. Our studies were not designed to assess
he prepatent period of T. leonina in cats; however, the
esults of the pre-treatment faecal examinations indicate
 prepatent period of less than nine weeks for the iso-
ates derived from both, cheetah and domestic cat, with
ome more variability in the former. Despite not being
ell deﬁned, these ﬁndings may  be useful for experimental
nfection study protocols, because induced ascarid infec-
ions, in general, are prone to spontaneous expulsion of the
orms.
The results of these two studies using induced infec-
ions with T. leonina demonstrated a high level of efﬁcacy of
he novel topical combination of ﬁpronil, (S)-methoprene,
prinomectin and praziquantel. These data complement
he results of the studies which were conducted to evalu-
te the efﬁcacy of Broadline® against Toxocara cati (Knaus
t al., 2014a,b).
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